Inverness Counsel’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $380K | Buy |
2,830
+959
| +51% | +$129K | 0.02% | 140 |
|
|
2022
Q2 | $287K | Sell |
1,871
-106
| -5% | -$16.3K | 0.02% | 144 |
|
|
2022
Q1 | $320K | Buy |
1,977
+15
| +0.8% | +$2.43K | 0.01% | 146 |
|
|
2021
Q4 | $266K | Buy |
+1,962
| New | +$266K | 0.01% | 167 |
|
|
2018
Q2 | – | Sell |
-2,140
| Closed | -$203K | – | 134 |
|
|
2018
Q1 | $203K | Sell |
2,140
-30
| -1% | -$2.85K | 0.01% | 138 |
|
|
2017
Q4 | $210K | Buy |
+2,170
| New | +$210K | 0.01% | 96 |
|
|
2016
Q4 | – | Sell |
-4,080
| Closed | -$257K | – | 93 |
|
|
2016
Q3 | $257K | Sell |
4,080
-223,830
| -98% | -$14.1M | 0.02% | 79 |
|
|
2016
Q2 | $14.1M | Sell |
227,910
-145,619
| -39% | -$9.02M | 1.1% | 35 |
|
|
2016
Q1 | $21.3M | Buy |
373,529
+13,430
| +4% | +$767K | 1.66% | 26 |
|
|
2015
Q4 | $21.3M | Sell |
360,099
-12,625
| -3% | -$748K | 1.61% | 28 |
|
|
2015
Q3 | $20.3M | Buy |
372,724
+12,423
| +3% | +$676K | 1.72% | 23 |
|
|
2015
Q2 | $24.2M | Buy |
360,301
+36,703
| +11% | +$2.47M | 1.76% | 22 |
|
|
2015
Q1 | $18.9M | Buy |
323,598
+316,040
| +4,182% | +$18.5M | 1.39% | 27 |
|
|
2014
Q4 | $495K | Sell |
7,558
-1,132
| -13% | -$74.1K | 0.04% | 85 |
|
|
2014
Q3 | $502K | Buy |
8,690
+3,082
| +55% | +$178K | 0.04% | 84 |
|
|
2014
Q2 | $317K | Buy |
+5,608
| New | +$317K | 0.02% | 98 |
|